On September 23, 2025, AmplifAI, a leading AI-powered platform transforming enterprise contact center performance, announced it has raised $33.7 million in Series B funding and credit facility. The round was led by CVS Health Ventures, with participation from existing investors LiveOak Ventures and Dallas Venture Partners. This investment will accelerate AmplifAI’s mission to unify human and AI agent performance and deliver best-in-class customer experience at scale. Wilson Sonsini Goodrich & Rosati advised AmplifAI on the transaction.

The Wilson Sonsini team that advised AmplifAI included Brian Dillavou, Lucas Sheets, Daniel Cowan, and Margaret LaMore.

For more information, please see AmplifAI’s press release.